The benefit of biventricular pacing in appropriate patients with congestive heart failure (CHF) now has been established in terms of both morbidity and mortality. [1,2,3,4,5] Current criteria for ...

Discordant results from two trials comparing conduction system pacing with biventricular pacing for cardiac resynchronization therapy (CRT) leave open the question of whether conduction system pacing ...

The BLOCK HF trial demonstrated that, during continual cardiac pacing, adverse left ventricular remodelling and deterioration of systolic function occurred more frequently with right ventricular than ...

Patients with indications for cardiac resynchronization therapy (CRT) have better clinical outcomes when they undergo left bundle branch area pacing (LBBAP) rather than conventional biventricular ...

To the Editor: Yu et al. (Nov. 26 issue) 1 found that among patients with bradycardia, the left ventricular ejection fraction at 12 months was 7 percentage points lower in the patients who were ...

The global biventricular pacemakers market is on a sustained growth trajectory, with 2024 revenues estimated at $2.27 billion, building on the $2.1 billion recorded in 2023. Analysts forecast the ...

ST. PAUL, Minn.--(BUSINESS WIRE)--Aug. 25, 2004--St. Jude Medical, Inc. (NYSE:STJ) announced today U.S. Food and Drug Administration (FDA) approval and first implants of the Frontier(TM) II ...

Dublin, Nov. 02, 2021 (GLOBE NEWSWIRE) -- The "United States Pacemaker Market, By Type (MRI Compatible Pacemakers, Conventional Pacemakers), By Product Type (Implantable Pacemaker, External Pacemaker) ...